Publicaciones en colaboración con investigadores/as de Lund University (9)

2016

  1. Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort

    British Journal of Cancer, Vol. 115, Núm. 4, pp. 480-489

  2. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Cancer Letters, Vol. 375, Núm. 2, pp. 384-389

2015

  1. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours

    International Journal of Cancer, Vol. 136, Núm. 5, pp. E252-E261

2013

  1. snoRNPs regulate telomerase activity in neuroblastoma and are associated with poor prognosis

    Translational Oncology, Vol. 6, Núm. 4, pp. 447-457

2011

  1. Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas

    Genes Chromosomes and Cancer, Vol. 50, Núm. 4, pp. 250-262

  2. Prognostic value of SOX2 expression in neuroblastoma

    Genes Chromosomes and Cancer

2009

  1. HIF-1α induces MXI1 by alternate promoter usage in human neuroblastoma cells

    Experimental Cell Research, Vol. 315, Núm. 11, pp. 1924-1936

  2. HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 39, pp. 16805-16810

2006

  1. Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype

    Cancer Cell, Vol. 10, Núm. 5, pp. 413-423